Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Biomarker Detection in Association Studies: Modeling SNPs Simultaneously via Logistic ANOVA.
Epigenetics in NG2 glia cells.
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
Diagnostic uncertainty of tumefactive cystic demyelinating lesions.
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge.
Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.
Self-intermittent catheterization in multiple sclerosis.
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Central Neuropathic Pain Syndromes.
Validation of the Social Provisions Scale in People With Multiple Sclerosis.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
Gait and six-minute walk performance in persons with multiple sclerosis.
Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats.
Caregiving in Multiple Sclerosis and Quality of Life: A Meta-synthesis of Qualitative Research.
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.
HSV1 and 2 Detection in the CSF of Multiple Sclerosis Patients by Real-time PCR.
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.
Neurobehavioral disorders.
Pages
« first
‹ previous
…
292
293
294
295
296
297
298
299
300
…
next ›
last »